Tissue Protein Lysate, Ovary: right
$350.00
3 Days*
Specifications
| Product Data | |
| Disease State | Cancer |
|---|---|
| Diagnosis Category | Ovarian Cancer |
| Sample ID | FR00026DEE |
| Case ID | CI0000008140 |
| Prep | 2P |
| Vial ID | PL000025B2 |
| Tissue of Origin | Ovary: right |
| Site of Finding | Ovary: right |
| Appearance | Tumor |
| Sample Diagnosis (from Pathology Verification) | Adenocarcinoma of ovary, endometrioid |
| Normal | 0% |
| Lesional | 0% |
| Tumor | 70% |
| Tumor Hypo/Acellular Stroma | 0% |
| Tumor Hypercellular Stroma | 20% |
| Necrosis | 10% |
| T (Extent of Primary Tumor) | T2b |
| N (Lymph node metastasis) | N0 |
| M (Distant metastasis) | MX |
| CASE Diagnosis (from medical center path report) | Adenocarcinoma of ovary, endometrioid |
| Age | 80 |
| Gender | Female |
| Tumor Grade | FIGO G3: Poorly differentiated |
| Minimum Stage Grouping | IIB |
| Storage | Store the tissue lysate at -80°C. |
| Stability | These products are stable for one year from date of shipping when stored at -80°C without repeated freeze/thaws. |
| Shipping | Dry Ice |
Reviews
Documents
| Datasheet | |
| SDS | |
Citations
Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers
Abou-Fadel, Qu, Gonzalez et al
Oncol. Rep. (2020) 43 (6), 1945-1963 DOI: 10.3892/or.2020.7550
Abou-Fadel, Qu, Gonzalez et al
Oncol. Rep. (2020) 43 (6), 1945-1963 DOI: 10.3892/or.2020.7550
Cited by 34
AI Summary: OriGene's TissueScan™ Real-Time PCR panels (HMRT100, 103, CSRT502) and Human β-actin control primer set were used to assess the endogenous expression levels of CCM2 isoforms across different tissues at the transcriptional level in this study.
Snippet: TissueScan Real-Time PCR panels (HMRT100, 103, CSRT502) with Human β-actin control primer set (Origene) were used to determine the endogenous expression levels of CCM2 isoforms among the different tissues at the transcriptional level;- TissueScan Real-Time PCR panels (HMRT100, 103, CSRT502) with Human β-actin control primer set (Origene) were used to determine the endogenous expression levels of CCM2 isoforms among the different tissues at the transcriptional level;- TissueScan Real‑Time PCR panels (HMRT100, 103, CSRT502) with Human β‑actin control primer set (Origene) were used to determine the endogenous expression levels of CCM2 isoforms among the different tissues at the transcrip‑ tional level
Showing 1-1 of 1 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.
